Literature DB >> 11017046

Use of G-protein fusions to monitor integral membrane protein-protein interactions in yeast.

K N Ehrhard1, J J Jacoby, X Y Fu, R Jahn, H G Dohlman.   

Abstract

The control of protein-protein interactions is a fundamental aspect of cell regulation. Here we describe a new approach to detect the interaction of two proteins in vivo. By this method, one binding partner is an integral membrane protein whereas the other is soluble but fused to a G-protein gamma-subunit. If the binding partners interact, G-protein signaling is disrupted. We demonstrate interaction between known binding partners, syntaxin 1a with neuronal Sec1 (nSec1), and the fibroblast-derived growth factor receptor 3 (FGFR3) with SNT-1. In addition, we describe a genetic screen to identify nSec1 mutants that are expressed normally, but are no longer able to bind to syntaxin 1a. This provides a convenient method to study interactions of integral membrane proteins, a class of molecules that has been difficult to study by existing biochemical or genetic methods.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017046     DOI: 10.1038/80274

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  14 in total

1.  A novel approach for the identification of protein-protein interaction with integral membrane proteins.

Authors:  M Hubsman; G Yudkovsky; A Aronheim
Journal:  Nucleic Acids Res       Date:  2001-02-15       Impact factor: 16.971

2.  Adaptation of the Ras-recruitment system to the analysis of interactions between membrane-associated proteins.

Authors:  Fabian Köhler; Kristian M Müller
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

3.  Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation.

Authors:  R Paulmurugan; S S Gambhir
Journal:  Anal Chem       Date:  2003-04-01       Impact factor: 6.986

4.  Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies.

Authors:  R Paulmurugan; Y Umezawa; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

5.  Molecular imaging of drug-modulated protein-protein interactions in living subjects.

Authors:  Ramasamy Paulmurugan; Tarik F Massoud; Jing Huang; Sanjiv S Gambhir
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

Review 6.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

7.  Examining protein protein interactions using endogenously tagged yeast arrays: the cross-and-capture system.

Authors:  Bernhard Suter; Michael J Fetchko; Ralph Imhof; Christopher I Graham; Ingrid Stoffel-Studer; Caroline Zbinden; Maanasa Raghavan; Lianet Lopez; Lucija Beneti; Jacqueline Hort; Jeffrey Fillingham; Jack F Greenblatt; Guri Giaever; Corey Nislow; Igor Stagljar
Journal:  Genome Res       Date:  2007-11-07       Impact factor: 9.043

8.  Identification of novel ErbB3-interacting factors using the split-ubiquitin membrane yeast two-hybrid system.

Authors:  Safia Thaminy; Daniel Auerbach; Anthony Arnoldo; Igor Stagljar
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

9.  Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutations.

Authors:  Hidehisa Yamada; Keiji Furuuchi; Tetsuya Aoyama; Akihiko Kataoka; Jun-ichi Hamada; Mitsuhiro Tada; Shunichi Okushiba; Satoshi Kondo; Tetsuya Moriuchi; Hiroyuki Katoh
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 10.  Yeast two-hybrid, a powerful tool for systems biology.

Authors:  Anna Brückner; Cécile Polge; Nicolas Lentze; Daniel Auerbach; Uwe Schlattner
Journal:  Int J Mol Sci       Date:  2009-06-18       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.